Assembly MeasureChaptered/Signed
AR 105: Relative to Amyotrophic Lateral Sclerosis Awareness Month.
What AR 105 does, verified June 4, 2026
<p>This resolution aims to raise awareness about Amyotrophic Lateral Sclerosis (ALS) during ALS Awareness Month. It encourages Californians to support individuals affected by ALS and promotes research for treatments and a cure.</p>
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
✓Second ChamberComplete
✓GovernorComplete
6ChapteredCurrent
Last action: Read. Adopted. (Page 5000.). (2026-05-11)Alert me
Quick answers about AR 105
- What is the current status of AR 105?
- As of June 4, 2026, AR 105 is recorded as "Chaptered/Signed": it has been signed by the Governor and chaptered into law. The last recorded action, on May 11, 2026, was "Read. Adopted. (Page 5000.)".
- Did AR 105 pass?
- Yes. AR 105 passed both houses and was signed into law (last action May 11, 2026). Most California bills signed in a given year take effect on January 1 of the following year, unless the bill carries an urgency clause or sets its own operative date.
- Who wrote AR 105, and where is it now?
- AR 105 was authored by Asm. Rick Chavez Zbur with 12 coauthors.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions6 total · showing 5
| May. 11, 2026 | Read. Adopted. (Page 5000.). |
| May. 11, 2026 | Coauthors revised. |
| May. 04, 2026 | From committee: Be adopted. Ordered to Third Reading. (Ayes 9. Noes 0.) (May 4). |
| May. 04, 2026 | Coauthors revised. |
| Apr. 27, 2026 | Referred to Com. on RLS. |
Latest bill textIntroduced version, April 13, 2026 · 336 words
CALIFORNIA LEGISLATURE— 2025–2026 REGULAR SESSION
House Resolution
No. 105
| Introduced by Assembly Member Zbur (Coauthors: Assembly Members Alanis, Boerner, Dixon, Jeff Gonzalez, Papan, Ransom, and Ward) |
April 13, 2026 |
Relative to Amyotrophic Lateral Sclerosis Awareness Month.
LEGISLATIVE COUNSEL'S DIGEST
HR 105, as introduced, Zbur.
WHEREAS, Amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig’s disease, is a progressive fatal neurodegenerative disease in which a person’s brain loses connection with their muscles, slowly reducing a person’s ability to walk, talk, eat, and eventually breathe; and
WHEREAS, Thousands of new ALS cases are reported every year, and estimates show that every 90 minutes someone is diagnosed with ALS and someone passes away from ALS; and
WHEREAS, On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis; and
WHEREAS, The exact causes of ALS are unknown and there is no known cure for ALS; and
WHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service; and
WHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS; and
WHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS; and
WHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease; now, therefore, be it
Resolved by the Assembly of the State of California, That the Assembly hereby proclaims the month of May 2026 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease; and be it further
Resolved, That the Chief Clerk of the Assembly shall transmit copies of this resolution to the author for appropriate distribution.
Text of AR 105 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions